Hygiene and wellness company Pee Safe has successfully secured $3 million in funding for its ongoing Series B round, marking significant progress toward its total fundraising target of $6 million.
The funding for this round was spearheaded by Natco Pharma Limited, a prominent pharmaceutical company. Supporting their efforts were Rainmatter Health, backed by Nithin Kamath and Nikhil Kamath, the Founders of Zerodha, alongside participation from Alkemi Growth Capital, an existing investor.
In June 2021, the Gurugram-based company successfully secured approximately $3 million in its pre-Series B round. According to a press release by Pee Safe, these new funds will be deployed to support the company’s expansion efforts within India, facilitate overseas growth, and bolster marketing and awareness initiatives.
Founded in 2013 by Vikas Bagaria and Srijana Bagaria, Pee Safe has transformed itself into a prominent brand within the personal hygiene and fast-moving consumer goods (FMCG) sector. Over the last six years, the company has expanded its product portfolio to cover a wide array of personal hygiene categories, catering to the requirements of individuals from puberty through to menopause.
At present, Pee Safe is accessible through an extensive network of over 15,000 physical retail outlets spread across more than 70 cities in India. Additionally, the brand maintains a robust online presence on leading e-commerce platforms. According to the company, it also exports its products to 20 countries across five continents.
Although Pee Safe has not yet filed its FY23 results, the company asserts that it has maintained an impressive compound annual growth rate (CAGR) of 100% over the past five years.
